Abstract
According to Norbert Wiehner, the creator of cybernetics, intrapolation is from God, and extrapolation from the devil. The study of the future is a difficult science. The short term predictions are almost always wrong, and the long term predictions cannot be tested. But when I remain near the present repetitions are unavailable. The thrombolytic agent of the 1990s will surely be an intravenous preparation with high clot selectivity, despite the fact that all of the presently available intravenous thrombolytic agents have a lower success rate than intracoronary streptokinase. The agent of choice is rt-PA at this time; clinical data concerning pro-urokinase and other agents will soon be available.
Keywords
- Acute Myocardial Infarction
- Acute Pancreatitis
- Thrombolytic Therapy
- Thrombolytic Agent
- Short Term Prediction
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Effert, S., Verstraete, M. (1986). What should be the future strategy?. In: Effert, S., von Essen, R., Hugenholtz, P.G., Uebis, R., Verstraete, M. (eds) Facts and Hopes in Thrombolysis in Acute Myocardial Infarction. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-07174-8_29
Download citation
DOI: https://doi.org/10.1007/978-3-662-07174-8_29
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-662-07176-2
Online ISBN: 978-3-662-07174-8
eBook Packages: Springer Book Archive